KMK 1199/2025 Fornas status was re-audited for this indication and formulation through the official decision page: https://farmalkes.kemkes.go.id/unduh/keputusan-menteri-kesehatan-republik-indonesia-nomor-hk-01-07-menkes-1199-2025-tentang-formularium-nasional/
The searchable e-Fornas catalogue was cross-checked at: https://e-fornas.farmalkes.kemkes.go.id/guest/landing
Policy route: Existing FKTP controller-pathway optimization. Should salmeterol/fluticasone remain a preferred maintenance option when budesonide/formoterol MART reduces severe exacerbations?
GINA 2025 prefers ICS-formoterol MART for exacerbation reduction: https://ginasthma.org/2025-gina-strategy-report/
Cochrane MART review: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009019.pub2/full